Approved for Prevention of invasive disease caused by Haemophilus influenzae type b in infants and children ages 2 months through 5 years. Contains purified capsular polysaccharide of Haemophilus influenzae type b (Hib) linked to tetanus toxoid protein. This conjugation enhances the immune response in young children, who otherwise… Side effects, costs, interactions, manufacturer, and generic…
Loading full data from Know Your Drugs Institute…